This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Celis, J. E. Articles by Celis, A. Search for Related Content PubMed PubMed Citation Articles by Celis, J. E. Articles by Celis, A.

Proteomics and Immunohistochemistry Define Some of the Steps Involved in the Squamous Differentiation of the Bladder Transitional Epithelium

A Novel Strategy for Identifying Metaplastic Lesions¹

Department of Medical Biochemistry and Danish Centre for Human Genome Research, The University of Aarhus [J. E. C., P. C., M. Ø., B. B., J. B. L., G. R., H. H. R., A. C.], and Department of Clinical Biochemistry, Aarhus University Hospital [T. F. Ø.], DK-8000 Aarhus C; and Department of Urology, Skejby Hospital, DK-8200, Aarhus N [B. H., H. W.], Denmark

Here, we present a novel strategy for dissecting some of the steps involved in the squamous differentiation of the bladder urothelium leading to squamous cell carcinomas (SCCs). First, we used proteomic technologies and databases (http://biobase.dk/cgi-bin/celis) to reveal proteins that were expressed specifically by fresh normal urothelium and three SCCs showing no urothelial components. Thereafter, antibodies against some of the differentially expressed proteins as well as a few known keratinocyte markers were used to stain serial cryostat sections (immunowalking) of biopsies obtained from bladder cystectomies of two of the SCC-bearing patients (884-1 and 864-1). Because bladder cancer is a field disease, we surmised that the urothelium of these patients may exhibit a spectrum of abnormalities ranging from early metaplastic stages to invasive disease. Immunohistochemical analysis revealed three types of nonkeratinizing metaplastic lesions (types 1–3) that did not express keratins 7, 8, 18, and 20 (expressed by normal urothelium) and could be distinguished based on their staining with keratin 19 antibodies. Type 1 lesions showed staining of all cell layers in the epithelium (with differences in the staining intensity of the basal compartment), whereas type 2 lesions exhibited mainly basal cell staining. Type 3 lesions did not stain with keratin 19 antibodies. In cystectomy 884-1, type 3 lesions exhibited the same immunophenotype as the SCC and may be regarded as precursors to the tumor. Basal cells in these lesions did not express keratin 13, suggesting that the tumor, which was also keratin 13 negative, may have arisen from the expansion of these cells. Similar results were observed with cystectomy 864-1, which showed carcinoma in situ of the SCC type. SCC 864-1 exhibited both keratin 19-negative and -positive cells, implying that the tumor arose from the expansion of the basal cell compartment of type 2 and 3 lesions. Besides providing with a novel strategy for revealing metaplastic lesions, our studies have shown that it is feasible to apply powerful proteomic technologies to the analysis of complex biological samples under conditions that are as close as possible to the in vivo situation.

This article has been cited by other articles:

				A. Lopez-Beltran, M. J Requena, J. Alvarez-Kindelan, A. Quintero, A. Blanca, and R. Montironi Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry J. Clin. Pathol., March 1, 2007; 60(3): 332 - 335. [Abstract] [Full Text] [PDF]

				J. E. Celis, P. Gromov, I. Gromova, J. M. A. Moreira, T. Cabezon, N. Ambartsumian, M. Grigorian, E. Lukanidin, P. thor Straten, P. Guldberg, et al. Integrating Proteomic and Functional Genomic Technologies in Discovery-driven Translational Breast Cancer Research Mol. Cell. Proteomics, June 1, 2003; 2(6): 369 - 377. [Abstract] [Full Text] [PDF]

				B. J. Duggan, J. J. McKnight, K. E. Williamson, M. Loughrey, D. O'Rourke, P. W. Hamilton, S. R. Johnston, C. C. Schulman, and A. R. Zlotta The Need to Embrace Molecular Profiling of Tumor Cells in Prostate and Bladder Cancer Clin. Cancer Res., April 1, 2003; 9(4): 1240 - 1247. [Abstract] [Full Text] [PDF]

				P. Gromov, G. L. Skovgaard, H. Palsdottir, I. Gromova, M. Ostergaard, and J. E. Celis Protein Profiling of the Human Epidermis from the Elderly Reveals Up-regulation of a Signature of Interferon-{gamma}-induced Polypeptides That Includes Manganese-superoxide Dismutase and the p85{beta} Subunit of Phosphatidylinositol 3-Kinase Mol. Cell. Proteomics, February 1, 2003; 2(2): 70 - 84. [Abstract] [Full Text] [PDF]

				J. E. Celis, P. Celis, H. Palsdottir, M. Ostergaard, P. Gromov, H. Primdahl, T. F. Orntoft, H. Wolf, A. Celis, and I. Gromova Proteomic Strategies to Reveal Tumor Heterogeneity among Urothelial Papillomas Mol. Cell. Proteomics, April 1, 2002; 1(4): 269 - 279. [Abstract] [Full Text] [PDF]